Fludarabine-Cl

• Description :

  Fludarabine-Cl has an inhibitory effect on RNA adenosine deaminase 1 (ADAR1) with an IC50 of 0.87 μM and can be used to prevent and/or study cancer or tumor-related diseases[1].

• UNSPSC :

  12352005

• Target :

  Adenosine Deaminase

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/fludarabine-cl.html

• Concentration :

  10mM

• Purity :

  99.71

• Solubility :

  H2O : 5 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles :

  NC1=C2C(N([C@]3([H])O[C@@H]([C@H]([C@H]3O)O)CCl)C=N2)=NC(F)=N1

• Molecular Formula :

  C10H11ClFN5O3

• Molecular Weight :

  303.68

• References & Citations :

  [1]Polysubstituted purine compound and preparation method and application thereof. CN113549076A.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2734853-80-4]